Back

MicroRNA signatures in dilated cardiomyopathy: diagnostic performance and prognostic value from the European BestAgeing study

9 May 2026 (08:00 - 12:45)
Organised by: Logo
Congress Presentation Part of: Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure Biomarkers Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Christoph Reich

University Hospital Heidelberg, Heidelberg (Germany)

4 More presentations in this session

Presentation thumbnail
sST2 and CA125 identify distinct biological phenotypes and predict mortality in very old patients hospitalised for acute HFpEF
Mrs B. Del Hoyo Cuenda (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Blood urea nitrogen to creatinine ratio, clinical outcomes, and effect of finerenone in HFmrEF/HFpEF: findings in FINEARTS-HF
Doctor R. Ono (Glasgow, GB)
Abstract Slides Video
Presentation thumbnail
Serum transthyretin before and after starting tafamidis as outcome predictors in ATTR cardiomyopathy
Doctor V. Castiglione (Pisa, IT) Doctor A. Aimo (Pisa, IT)
Abstract Slides Video
Presentation thumbnail
Molecular signatures of accelerated ageing in heart failure: a multi-protein analysis
Ms J. Lee (Singapore, SG)
Abstract Video

Access the full session

Session thumbnail
Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure
Video

The Event

Event poster

Heart Failure 2026

9 May - 12 May 2026
You may be interested in
thumbnail
Congress Session
Contemporary biomarkers for diagnosis, monitoring, and prognosis in heart failure
thumbnail
Congress Session
Biomarkers in cardiomyopathies: recent advances
thumbnail
Congress Session
Mechanisms of heart failure: emerging evidence

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources